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Abstracts / Osteoarthritis and Cartilage 23 (2015) A26eA81 A73Methods: Genomic DNA was isolated from human macroscopically pre-
served (N¼11) and OA (N¼12) knee articular cartilage. After bisulphite
treatment, DNA was proﬁled using the Illumina Inﬁnium Human-
Methylation450 beadchip. For transcriptomic analysis, RNA isolated from
normal (N¼8) and OA (N¼10) knee articular cartilage was sequenced
using the Illumina HiSeq 2000 platform. In both cases, normalized data
was analyzed using a custom-made R bioconductor package. For in vitro
experiments, primary chondrocytes isolated from donors with normal
(N¼5) cartilage, and TC28 immortalized chondrocytes were used. Cells
were cultured inmonolayer until conﬂuence, treatedwith different doses
of the DNA methylation inhibitor 5-Aza-2-deoxycytidine (5’Aza) or
vehicle, and gene expression was assessed by qPCR.
Results: DNA methylation proﬁling revealed 3259 differentially methy-
lated sites (DMS) between normal and OA cartilage (p<0.05, FDR0.15)
that comprised a total of 1269 genes. Compared with all the CpG sites
included in the array, DMSwere signiﬁcantly enriched in gene bodies and
enhancer regions of the genome, and depleted in CpG islands and pro-
moter regions. Integrative analysis with RNAseq data showed that only
127 out of 1269 genes were also differentially transcribed in OA cartilage.
To assess the functional consequences of the different methylation
landscapes, we identiﬁed 73 genes that showed an inverse correlation
between methylation and gene expression. Interestingly, this group of
genes included a subset of 10 transcription factors that were signiﬁcantly
hypermethylated and downregulated in OA cartilage (ATOH8, FOXO3,
KLF15, MAFF, NCOR2, NFATC1, RARA, TBX4, ZBTB16 and ZHX2). In vitro
experiments in TC28 cells treated with 5’Aza showed a signiﬁcant pos-
itive correlation between 5’Aza concentration and gene expression for
ATOH8, FOXO3, KLF15, MAFF, NCOR2, RARA, TBX4 and ZBTB16. However,
in primary chondrocytes only FOXO3 and TBX4 showed a signiﬁcant
increase in gene expression upon 5’Aza treatment.
Conclusions: The present results reveal a striking correlation between a
relatively large number of transcription factors that were hyper-
methylated and downregulated in OA cartilage. These ﬁndings suggest
that methylation-related changes of several important transcription
factors represent an important mechanism that may explain changes in
chondrocyte transcriptome and function in OA.
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Purpose: Although the progression of osteoarthritis (OA) is generally
currently unpredictable, altered biomechanical and biochemical prop-
erties of the joint organ facilitate progression of disease. It is widely
accepted that the molecular homeostasis of the joint depends on both
the structural integrity of articular cartilage and the appropriate bio-
mechanical stresses. A detailed examination of molecular changes in
cartilage is of pivotal importance for choosing molecules that could
potentially be targeted to achieve a therapeutic beneﬁt. However,
results of molecular analyses of advancedmedial compartment knee OA
tissue may not only represent direct effects of disease, but also site-
related effects driven by altered mechanical loading. To overcome these
obstacles, we have pursued a two-pronged approach. First cartilage
gene expression changes relative to a gradient of histological OA
severity across the tibial plateau in knees with medial compartment
dominant disease (MOA) (Figure panel A) were proﬁled to identify
disease relevant and potential OA progression related genes. Second,
cartilage gene expression changes relative to a gradient of histological
OA severity across the tibial plateau in knees with lateral compartment
dominant disease (LOA) were used to validate this OA progression
model system (Figure panel B). Because load plays less of a role in
development of LOA than MOA, we hypothesized that the identiﬁcation
of the severity associated genes expressed in common between medial
and lateral compartment dominant disease may more readily identify
genes related to biological factors directly associated with OA pro-
gression that are independent of load.
Methods: We evaluated histological and transcriptomic changes of
regions of interest across the tibial plateau encompassing a wide range
of disease severities (Figure A-D). Gene expression of knee cartilage was
comprehensively assessed for three regions of interest across the tibialplateau from human medial dominant OA (n¼10) and non-OA (n¼6)
specimens. Histology and gene expression were compared for the
regions with minimal degeneration, moderate degeneration and sig-
niﬁcant degeneration. Agilent whole-genome microarray was per-
formed and data were analyzed using Agilent GeneSpring GX11.5.
Signiﬁcant differentially regulated genes were further investigated by
Ingenuity Pathway Analysis (IPA) to identify functional categories. To
conﬁrm their associationwith disease severity as opposed to site within
the knee, 30 differentially expressed genes, identiﬁed by microarray,
were analyzed by quantitative reverse-transcription polymerase chain
reaction on additional medial (n¼16) and lateral (n¼10) compartment
dominant knee OA samples.
Results: A total of 767 genes were differentially expressed >two-fold (P
0.05) in lesion compared to relatively intact regions. Analysis of these
data by IPA predicted biological functions related to an imbalance of
anabolism and catabolism of cartilage matrix components. Up-regu-
lated expression of IL11, POSTN, TNFAIP6, and down-regulated expres-
sion of CHRDL2, MATN4, SPOCK3, VIT, PDE3B were signiﬁcantly
associated with OA progression and validated in both medial and lateral
compartment dominant OA samples (Figure E).
Conclusions: A comparison between MOA and LOA gene expression
was applied in our study to characterize differentially expressed genes
that may represent genes directly involved with OA disease progression
as opposed to site-related effects driven by altered mechanical loading.
Our study provides a strategy for identifying targets whose mod-
iﬁcation may have the potential to ameliorate pathological alternations
and progression of disease in cartilage and to serve as biomarkers for
identifying individuals susceptible to progression.
86
RISK PREDICTION USING EPIGENETIC PROFILES IN BLOOD OF
OSTEOARTHRITIS PATIENTS
Y.F. Ramos, W. den Hollander, N. Lakenberg, R. van der Breggen,
N. Bomer, H. Kroon, M. Kloppenburg, P. Slagboom, I. Meulenbelt. Leiden
Univ. Med. Ctr., Leiden, Netherlands
Purpose: Previous studies have highlighted the urgent need for bio-
markers to predict OA progression in the clinic, preferably with an AUC
